Medicare Enrolled
Dr. Rajesh Shetty, MD
Pulmonary Disease · Kyle, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shetty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shetty?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shetty
Dr. Rajesh Shetty is a pulmonary disease specialist in Kyle, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shetty performed 4,727 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shetty received a total of $7,370 from 22 pharmaceutical and/or device companies across 196 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shetty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 5% volume in TX
$7,370 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,727
Medicare services
Top 5% in TX for pulmonary disease
Not available
Unique patients (not deduplicated)
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
713 | $25 | $159 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
676 | $93 | $225 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
659 | $38 | $140 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
653 | $29 | $111 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
612 | $24 | $97 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
318 | $88 | $512 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
234 | $63 | $145 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
194 | $157 | $1,541 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
178 | $135 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
154 | $131 | $543 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $121 | $300 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
56 | $12 | $30 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
37 | $11 | $25 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
35 | $14 | $25 |
| New patient office visit, complex (60-74 min) | 33 | $167 | $400 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
23 | $23 | $442 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $69 | $210 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
16 | $82 | $860 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
15 | $94 | $575 |
| Bronchoscopy A procedure to examine the airways inside the lungs using a thin, flexible tube with a camera. |
12 | $0 | $400 |
| Bronchoscopy A diagnostic exam of the lung airways using an endoscope to visually inspect the inside of the lungs and airways. |
11 | $99 | $958 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
11 | $55 | $303 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,370
Total received (2018-2024)
Avg $1,053/year across 7 years
Top 25% in TX for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
196
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,069
2023
$762
2022
$430
2021
$115
2020
$129
2019
$259
2018
$607
Payments by company (2024)
INTUITIVE SURGICAL, INC.
$3,894
AstraZeneca Pharmaceuticals LP
$321
Boehringer Ingelheim Pharmaceuticals, Inc.
$279
Regeneron Healthcare Solutions, Inc.
$152
Mylan Specialty L.P.
$132
Inspire Medical Systems, Inc.
$92
GENZYME CORPORATION
$88
Insmed, Inc.
$44
Actelion Pharmaceuticals US, Inc.
$32
Cook Medical LLC
$21
ANI Pharmaceuticals, Inc.
$16
Top 3 companies account for 88.6% of 2024 payments
All-time payments by company (2018-2024) ›
INTUITIVE SURGICAL, INC.
$3,894
AstraZeneca Pharmaceuticals LP
$708
Boehringer Ingelheim Pharmaceuticals, Inc.
$536
Olympus Corporation of the Americas
$485
Sunovion Pharmaceuticals Inc.
$456
Cook Medical LLC
$180
CSL Behring
$167
Regeneron Healthcare Solutions, Inc.
$152
Mylan Specialty L.P.
$132
Inspire Medical Systems, Inc.
$92
GENZYME CORPORATION
$88
Actelion Pharmaceuticals US, Inc.
$87
GlaxoSmithKline, LLC.
$76
Insmed, Inc.
$76
Philips Electronics North America Corporation
$63
Grifols USA, LLC
$44
Janssen Pharmaceuticals, Inc
$37
Circassia Pharmaceuticals Inc
$30
AbbVie Inc.
$30
ANI Pharmaceuticals, Inc.
$16
Itamar Medical Inc
$14
United Therapeutics Corporation
$8
Top 3 companies account for 69.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AVYCAZ · Arikayce · BROVANA · COOK MEDICAL ANGIOPLASTY · COOK MEDICAL STENTS · COOK MEDICAL ZILVER PTX · Cook Medical Catheters · DUPIXENT · Da Vinci Surgical System · FASENRA · INSPIRE · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · SINGLE USE SUCTION VALVE (Sterile) · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · Utibron · WatchPAT · XARELTO · YUPELRI · ZILVER VENA · Zemaira · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
23
County median income
$85,827
Nearest hospital to ZIP centroid (approximate)
ASCENSION SETON HAYS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shetty is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shetty experienced with spirometry test before and after medication?
Based on Medicare claims data, Dr. Shetty performed 713 spirometry test before and after medication services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shetty receive payments from pharmaceutical companies?
Yes. Dr. Shetty received a total of $7,370 from 22 companies across 196 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shetty's costs compare to other pulmonary diseases in Kyle?
Dr. Shetty's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shetty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Kyle
Browse pulmonary diseases in Kyle ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology